Pediatrix (NYSE: MD) officer files notice for $572,619.71 stock sale
Pediatrix Medical Group (MD) officer Mary Ann E. Moore filed a Rule 144 notice to sell 21,335 shares, valued at $572,619.71, through Merrill Lynch on the NYSE. The shares stem from vested stock awards, with 81,253,271 shares outstanding as of September 11, 2026. Moore previously sold 9,260 shares in August 2026.
How this was made
The 30-second read
Why it matters
The filing introduces a modest increase in float, which may exert slight downward pressure on MD's share price in the short term.
Market read
A routine insider sale filing with modest size; low immediate trading relevance but worth noting for short‑term price monitoring.
What to watch
Potential upcoming earnings or corporate actions that could offset the supply pressure.
Background
Form 144 filings are required for insiders to disclose planned sales of restricted shares, providing transparency on future share supply.
Ticker impact
Officer Mary Ann E. Moore filed a Form 144 to sell 21,335 shares of Pediatrix Medical Group (MD) worth $572,619.71, indicating new insider supply.
Potential short‑term dip of 1‑2% as the market absorbs the new share supply.
The transaction size is modest (<$1M) but represents a direct increase in float; such filings often precede slight price weakness.
Market effects
Minimal impact on the broader healthcare services sector; the filing is company‑specific.
Limited to U.S. investors tracking MD; no broader regional effect.
Negligible on a global scale.
Counterpoint
The sale could be unrelated to confidence and merely a liquidity need; the stock may remain stable.
Key entities
- OfficerMary Ann E. Moore
Pediatrix Medical Group officer filing the share sale.
- CompanyPediatrix Medical Group, Inc.
Healthcare services provider listed on NYSE under ticker MD.
